Werfen
Nan Ma is an experienced professional in regulatory affairs, currently serving as the International Regulatory Affairs Manager II for Werfen since August 2022, overseeing IVD product registration in China and Japan and addressing complex regulatory challenges. Prior roles include Manager of International Regulatory Affairs at Glaukos Corporation and Associate Territory Manager at Olympus Corporation of the Americas, where responsibilities encompassed managing regulatory submissions across multiple Asian markets. A background in regulatory affairs is complemented by positions at Medtronic and Abiomed, engaging in new product development and submissions in Japan. Earlier experience includes scientific research roles at Dana-Farber Cancer Institute and the University of Massachusetts Amherst, alongside a sales position at GD AEON and a teaching assistant role at Osaka University. Nan Ma holds a PhD in Biotechnology from Osaka University, an MSc in Molecular Biology from Hirosaki University, and a BS in Biology from Harbin Normal University.
This person is not in any teams
This person is not in any offices
Werfen
7 followers
Werfen is a global leader in in vitro diagnostics (IVD) in the specialties of Hemostasis, Critical Care and Autoimmunity. Our core business is dedicated to R&D, manufacturing and distribution of diagnostic systems for hospitals and clinical laboratories. Our other areas of expertise include Original Equipment Manufacturing, IVD & Clinical Software, Clinical Chemistry, Infusion Therapy, and Medical Devices Distribution.